Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of SLIT3 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLIT3 mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of SLIT3 mRNA | decreases expression | 20064835
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of SLIT3 mRNA | decreases expression | 18042831
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of SLIT3 mRNA | increases expression | 16404146
|
D008628 |
Mercury |
Mercury results in decreased expression of SLIT3 mRNA | decreases expression | 16823088
|
D015735 |
Mifepristone |
Mifepristone results in decreased expression of SLIT3 mRNA | decreases expression | 17584828
|
C041786 |
palm oil |
palm oil results in decreased expression of SLIT3 mRNA | decreases expression | 18042831
|
C025643 |
vinclozolin |
vinclozolin affects the expression of SLIT3 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.84 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.60 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.60 | 17418594 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.76 | 6695378 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.78 | 21441931 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.80 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.33 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.15 | 15238619 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.77 | 17497416 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
5.13 | 16634805 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.02 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.00 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.93 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.93 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.93 | 15136595 15994142 19526202 16595493 16096432 16935488 18628466 16322301 15668708 11325840 15939500 15692762 18695136 15567936 17983394 15993339 15634643 18234424 16826403 16115903 18382427 17426702 17369602 16264153 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.13 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.21 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
3.21 | 16023760 16234567 18059187 17876044 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.24 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.86 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.86 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.66 | 16109756 18627295 15505089 16651473 17131338 17382496 16364871 15792986 16731534 16278810 16455267 16612575 17007740 17928571 16242529 17974986 17519947 16952015 15476868 17924179 17308081 17351982 16269455 15811867 17329180 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
6.38 | 16243910 17334414 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
6.38 | 10334427 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.58 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.27 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
4.05 | 16823706 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
4.20 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
4.20 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.82 | 18602426 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.60 | 18367378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.58 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
4.56 | 16134523 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.47 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.05 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
3.44 | 19551842 19004024 17967931 18296743 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.87 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
3.78 | 18296743 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.22 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.62 | 16417039 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.47 | 17150277 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.66 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.75 | 20471113 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.62 | 16879835 18674790 12587719 16707910 16144979 16244372 16330681 16495754 17875725 17888722 18006777 16244371 14766674 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.46 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.11 | 15692506 |
MESH:D006548 |
Hernia, Diaphragmatic |
marker/mechanism |
|
| 17436238 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.59 | 18501091 15147373 17606976 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.80 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.83 | 21332399 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.17 | 16467254 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
2.52 | 20412841 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.23 | 18457598 11836018 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.92 | 15699352 15369732 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
6.92 | 17934191 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.36 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
3.14 | 16705839 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.47 | 16085563 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.02 | 16417039 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.98 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.15 | 16595196 16439617 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
2.10 | 21137059 20195826 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.13 | 17085340 16842330 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.57 | 20464547 17053015 18569708 20064080 18816296 20869020 18520028 20135361 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.57 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.60 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.96 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.83 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.15 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.31 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.13 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.70 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.35 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.08 | 17415656 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.02 | 19429709 15857846 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.14 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.02 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.25 | 11141357 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.03 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.18 | 15640375 16889571 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.36 | 15555623 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.33 | 11836018 20132043 19632207 17217161 21332399 20518802 16723640 18674790 18457598 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.62 | 12819281 16049721 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.28 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
3.18 | 16525653 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.47 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.47 | 17638057 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.18 | 19015723 18042343 18220299 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.22 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.23 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.23 | 16868541 15897917 15749863 18437689 16888761 16729912 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.22 | 18629315 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.48 | 17922066 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.18 | 15625365 17203757 15675481 17710206 18313854 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.48 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.08 | 17846226 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.66 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
6.09 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
6.09 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.83 | 17203757 16767912 15625365 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.52 | 17909728 16010429 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.74 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.74 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.74 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.60 | 10091137 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.48 | 16364871 17334414 17638931 17678736 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.92 | 16723640 |